Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA ALKEM LABORATORIES GSK PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 62.2 37.5 165.9% View Chart
P/BV x 18.9 6.5 289.2% View Chart
Dividend Yield % 1.6 1.0 162.7%  

Financials

 GSK PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
ALKEM LABORATORIES
Mar-23
GSK PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,6843,625 46.4%   
Low Rs1,2312,835 43.4%   
Sales per share (Unadj.) Rs191.9970.1 19.8%  
Earnings per share (Unadj.) Rs35.984.2 42.6%  
Cash flow per share (Unadj.) Rs39.8110.2 36.1%  
Dividends per share (Unadj.) Rs32.0050.00 64.0%  
Avg Dividend yield %2.21.5 141.9%  
Book value per share (Unadj.) Rs102.9756.4 13.6%  
Shares outstanding (eoy) m169.41119.57 141.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.63.3 228.0%   
Avg P/E ratio x40.638.4 105.9%  
P/CF ratio (eoy) x36.729.3 125.0%  
Price / Book Value ratio x14.24.3 331.7%  
Dividend payout %89.259.4 150.2%   
Avg Mkt Cap Rs m246,858386,207 63.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,95021,314 27.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,517115,993 28.0%  
Other income Rs m1,0072,161 46.6%   
Total revenues Rs m33,524118,153 28.4%   
Gross profit Rs m8,03315,065 53.3%  
Depreciation Rs m6583,104 21.2%   
Interest Rs m181,074 1.7%   
Profit before tax Rs m8,36413,048 64.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2882,980 76.8%   
Profit after tax Rs m6,07610,068 60.4%  
Gross profit margin %24.713.0 190.2%  
Effective tax rate %27.422.8 119.8%   
Net profit margin %18.78.7 215.3%  
BALANCE SHEET DATA
Current assets Rs m24,94386,064 29.0%   
Current liabilities Rs m13,26437,071 35.8%   
Net working cap to sales %35.942.2 85.0%  
Current ratio x1.92.3 81.0%  
Inventory Days Days9733 298.6%  
Debtors Days Days21667 321.8%  
Net fixed assets Rs m6,98837,245 18.8%   
Share capital Rs m1,694239 708.5%   
"Free" reserves Rs m15,73590,208 17.4%   
Net worth Rs m17,43090,447 19.3%   
Long term debt Rs m00-   
Total assets Rs m31,930124,541 25.6%  
Interest coverage x462.613.2 3,516.9%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.9 109.3%   
Return on assets %19.18.9 213.4%  
Return on equity %34.911.1 313.2%  
Return on capital %48.115.6 308.0%  
Exports to sales %014.6 0.0%   
Imports to sales %48.10-   
Exports (fob) Rs mNA16,916 0.0%   
Imports (cif) Rs m15,630NA-   
Fx inflow Rs m1,62216,916 9.6%   
Fx outflow Rs m15,6304,190 373.1%   
Net fx Rs m-14,00812,727 -110.1%   
CASH FLOW
From Operations Rs m4,84216,825 28.8%  
From Investments Rs m8,0791,128 715.9%  
From Financial Activity Rs m-15,433-17,608 87.6%  
Net Cashflow Rs m-2,512416 -603.7%  

Share Holding

Indian Promoters % 0.0 56.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 24.4 47.5%  
FIIs % 2.9 8.5 34.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 43.3 57.8%  
Shareholders   114,663 65,184 175.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs ALKEM LABORATORIES Share Price Performance

Period GSK Pharma ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 3.26% -1.18% 1.18%
1-Month -9.77% -0.99% -0.75%
1-Year 52.63% 52.26% 61.82%
3-Year CAGR 10.89% 21.70% 18.16%
5-Year CAGR 8.44% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.